{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-011909","form_type":"8-K","ticker":"RANI","cik":"0001856725","company_name":"Rani Therapeutics Holdings, Inc.","filed_at":"2023-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.299703+00:00","generated_at":"2026-06-17T06:03:17.829167+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Director Lyn Baranowski will not stand for re-election at 2023 annual meeting","bullets":["Lyn Baranowski notified Rani Therapeutics she will not stand for re-election at the 2023 annual meeting.","She will cease to be a board member and member of Compensation and Nominating/Governance committees effective at the meeting.","Decision not due to any disagreement with the company on operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-011909","json":"https://secwatch.observer/filing/0000950170-23-011909.json","markdown":"https://secwatch.observer/filing/0000950170-23-011909.md","text":"https://secwatch.observer/filing/0000950170-23-011909.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023011909/0000950170-23-011909-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023011909/rani-20230330.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T06:03:17.829167+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e908337df8","claim":"Lyn Baranowski departed as Director at Rani Therapeutics Holdings, Inc..","evidence_excerpt":"On March 30, 2023, Ms. Lyn Baranowski notified Rani Therapeutics Holdings, Inc. (the “Company”) that she does not intend to stand for re-election at the 2023 annual meeting of stockholders of the Company (“Annual Meeting”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1856725/000095017023011909/0000950170-23-011909-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"does not intend to stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}